Epilepsy affects approximately 1 percent of the human population, with an estimated 50 million people worldwide currently suffering from the disorder. The hallmark of epilepsy is the seizure ― a sudden and often violent event that strikes patients without warning.
Mayo Clinic is joining with the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation to study new ways to predict and control epileptic seizures in dogs and people. “Our goal is reliable seizure forecasting in conjunction with timely, effective short-term intervention, and this could lead to more effective treatment for both canine and human epilepsy,” says Greg Worrell M.D., Ph.D. , a neurologist at Mayo Clinic.
In the home video provided, a handler tries to comfort a dog suffering a seizure. Epilepsy is a common neurologic disease in dogs. According to the Canine Epilepsy Network, some studies estimate up to 4% of all dogs are affected, and in some breeds, the incidence may be higher.